Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Serum antibodies to Cyclic citrullinated peptides (Anti CCP) are now recognised to be a valuable marker of diagnostic and prognostic significance. ANA’s occur both in systemic and organ specific autoimmune diseases showing positivity in Rheumatoid arthritis.There is incremental value in testing for presence of both Rheumatoid factor (RF) and Anti CCP as some patients with RA are positive for RF but negative for Anti CCP and vice versa.
₹3,100.00Original price was: ₹3,100.00.₹3,000.00Current price is: ₹3,000.00.
Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Being a systemic disease, RA can result in a variety of extra-articular manifestations. ANA’s occur both in systemic and organ specific autoimmune disease showing positivity in Rheumatoid arthritis, Scleroderma, Sjogren’s syndrome, Mixed connective tissue disease and CREST syndrome
₹10,800.00Original price was: ₹10,800.00.₹9,500.00Current price is: ₹9,500.00.
Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. Being a systemic disease, RA can result in a variety of extra-articular manifestations. ANA’s occur both in systemic and organ specific autoimmune disease showing positivity in Rheumatoid arthritis, Scleroderma, Sjogren’s syndrome, Mixed connective tissue disease and CREST syndrome
₹6,200.00Original price was: ₹6,200.00.₹6,000.00Current price is: ₹6,000.00.
The risk of ovarian malignancy algorithm (ROMA) incorporates cancer antigen 125 (CA125), human epididymal protein 4 (HE4), and menopausal status to assign women that present with an adnexal mass into a high-risk or low-risk group for finding an ovarian malignancy
₹3,500.00Original price was: ₹3,500.00.₹3,000.00Current price is: ₹3,000.00.
